Peptides for Fat Loss: Complete Guide to GLP-1 and GH Options (2026)

Research-use note: This compound is supplied by Peptide+ strictly for laboratory and research purposes. Most of the evidence discussed here is preclinical or from early-stage human trials, and human data is limited. This article is educational and is not medical advice.

"Peptides for fat loss" covers a wide and often confusing field, from the GLP-1 receptor agonists that dominate the headlines to growth-hormone fragments, oral metabolic compounds, and brain-acting appetite modulators. They do not all work the same way, and they are not interchangeable. This guide is the practical map: it groups the main research compounds studied for fat loss by mechanism, summarises what the evidence actually supports, and links to the deep guide for each one. For the underlying biology of the most studied class, see our explainer on how GLP-1 weight-loss peptides work.

The Four Mechanistic Families

Most fat-loss research compounds fall into four buckets. Understanding which bucket a compound sits in tells you more than any single marketing claim, because it predicts how it acts, what it stacks well with, and where its limits are.

The GLP-1 Class: The Heavyweights

The incretin compounds are the most evidence-backed of any fat-loss research class, with large human trials behind the parent molecules. Semaglutide is the single-agonist benchmark, tirzepatide adds GIP activity for stronger results, and retatrutide adds a third (glucagon) receptor and has shown the largest reductions in trials so far. They work primarily by increasing satiety and slowing digestion, not by burning fat directly. See our ranked weight-loss peptide guide and the complete retatrutide guide for the deep dives.

GH Fragments: Lipolysis Without the GH Load

AOD-9604 is a fragment of human growth hormone engineered to isolate the fat-metabolism signalling region while avoiding effects on blood sugar or tissue growth. Tesamorelin, by contrast, stimulates the body's own growth-hormone release and is studied specifically for visceral fat. These are gentler, slower-acting options compared with the GLP-1 class. Our AOD-9604 vs semaglutide comparison sets realistic expectations.

Oral Metabolic Compounds: The Energy Angle

5-Amino-1MQ, MOTS-c, and SLU-PP-322 attack fat from the metabolic side rather than the appetite side, broadly by influencing how cells produce and spend energy. The research here is earlier and mostly preclinical, but the appeal is an oral or non-incretin route. Compare them in our MOTS-c vs 5-Amino-1MQ matchup.

Central Appetite Modulators

Tesofensine is not a peptide at all but a small molecule that acts on brain neurotransmitters (dopamine, noradrenaline, serotonin) to suppress appetite. It produced strong weight reductions in phase II trials and is often discussed alongside peptide options. See the tesofensine research guide for detail.

Choosing by Research Goal

The right compound depends entirely on the research question. The table below maps common goals to the family most studied for them.

Cost, Sourcing and Realistic Timelines

Fat-loss compounds vary widely in cost and in how quickly research models show change. Incretins are typically dosed weekly and show measurable change over weeks to months; GH fragments and oral metabolic compounds tend to be subtler. For budgeting see peptide weight-loss cost, and for expectations see how long until peptides work. Source only research-grade material with verifiable identity and purity from a reputable supplier.

Frequently Asked Questions

What are the best peptides for fat loss?

The most evidence-backed are the GLP-1 class (semaglutide, tirzepatide, retatrutide), which reduce appetite and slow digestion. Growth-hormone fragments like AOD-9604 and oral metabolic compounds like 5-Amino-1MQ are studied as alternatives with earlier evidence. The best choice depends on the specific research goal.

Do fat-loss peptides burn fat directly?

Mostly no. The GLP-1 class works by increasing satiety and slowing gastric emptying, so intake falls. Growth-hormone fragments act more directly on lipolysis pathways, and oral metabolic compounds shift cellular energy use. Only a few act on fat metabolism directly.

Which fat-loss peptide is strongest in trials?

Among the GLP-1 class, retatrutide (a triple receptor agonist) has shown the largest reductions in published trials, followed by tirzepatide and then semaglutide. These are the compounds with the most robust human data.

Are oral fat-loss compounds as effective as injections?

The evidence is not there yet. Oral metabolic compounds such as 5-Amino-1MQ and SLU-PP-322 are promising in preclinical work but lack the large human trials that the injectable GLP-1 class has. Treat them as earlier-stage research options.

How long do fat-loss peptides take to show results?

In research models the GLP-1 class shows measurable change over several weeks to a few months of consistent dosing. Growth-hormone fragments and oral metabolic compounds tend to act more gradually. See our timeline guide for detail.

How much do fat-loss peptides cost?

Cost varies widely by compound and dose. Incretins dosed weekly sit at one end and small research quantities of oral compounds at another. Our peptide weight-loss cost guide breaks down typical research-budget ranges.

Related Guides

• How GLP-1 Weight-Loss Peptides Work
• Best Peptides for Weight Loss
• The Complete Retatrutide Guide
• AOD-9604 vs Semaglutide
• Peptide Weight-Loss Cost
• How Long Until Peptides Work

Shop Research Peptides